David R. Walt - Jan 3, 2023 Form 4 Insider Report for Quanterix Corp (QTRX)

Role
Director
Signature
/s/ Brian Keane, as Attorney-in-Fact
Stock symbol
QTRX
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 03:03 PM
Previous filing
Aug 10, 2022
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QTRX Common Stock Award $0 +8.08K +0.56% $0.00 1.44M Jan 3, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QTRX Stock Option (Right to Buy) Award $0 +12.1K $0.00 12.1K Jan 3, 2023 Common Stock 12.1K $12.86 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest as to 100% of the shares on December 31, 2023 granted pursuant to the Quanterix Corporation Amended and Restated 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
F2 Includes 8,083 restricted stock units.
F3 Represents non-qualified stock option to purchase 12,124 shares of common stock granted pursuant to the Quanterix Corporation Amended and Restated 2018 Non-Employee Director Compensation Policy.